for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Teladoc Health Inc

TDOC.N

Latest Trade

139.68USD

Change

6.97(+5.25%)

Volume

844,469

Today's Range

134.59

 - 

141.80

52 Week Range

129.74

 - 

308.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
132.71
Open
134.59
Volume
844,469
3M AVG Volume
81.82
Today's High
141.80
Today's Low
134.59
52 Week High
308.00
52 Week Low
129.74
Shares Out (MIL)
154.53
Market Cap (MIL)
21,584.16
Forward P/E
-51.22
Dividend (Yield %)
--

Next Event

Teladoc Health Inc Annual Shareholders Meeting

Latest Developments

More

Teladoc Health Reports Q1 Loss Per Share Of $1.31

Teladoc Health Reports Q4 And Full-Year 2020 Results

Teladoc Health - For Q4 2020 Expect Total Rev To Be In Range Of $369 Mln To $379 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Teladoc Health Inc

Teladoc Health, Inc. provides virtual healthcare services. The Company provides virtual access to care with a portfolio of services and solutions, which includes various medical subspecialties from non-urgent, episodic needs, such as flu and upper respiratory infections, to chronic, complicated medical conditions, such as cancer and congestive heart failure. It provides virtual healthcare services on a business-to-business (B2B) basis to its clients and provides services to consumers directly and through channel partners. The Company’s consumer brands, including Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou, provides access to advice and resolution to a range of healthcare needs. Its technology enables consumers to manage their own electronic medical records. It also provides access to a message center, provider finder, image upload capability and enable real-time sharing capabilities with providers that includes visit scheduling.

Industry

Healthcare Facilities

Contact Info

2 Manhattanville Rd Ste 203

PURCHASE, NY

10577-2118

United States

+1.203.6352002

https://teladochealth.com/

Executive Leadership

David B. Snow

Independent Chairman of the Board

Jason N. Gorevic

Chief Executive Officer, Director

Mala Murthy

Chief Financial Officer

David Sides

Chief Operating Officer

Arnnon Geshuri

Chief Human Resource Officer

Key Stats

2.16 mean rating - 31 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.4K

2019

0.6K

2020

1.1K

2021(E)

2.0K
EPS (USD)

2018

-1.470

2019

-1.380

2020

-5.360

2021(E)

-2.733
Price To Earnings (TTM)
--
Price To Sales (TTM)
15.79
Price To Book (MRQ)
1.36
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
8.70
LT Debt To Equity (MRQ)
8.61
Return on Investment (TTM)
-6.96
Return on Equity (TTM)
-6.83

Latest News

Latest News

Teladoc bets big on online medicine with $18.5 billion Livongo deal

Teladoc Health Inc <TDOC.N> has agreed to buy chronic care provider Livongo Health Inc <LVGO.O> in a deal valuing the company at $18.5 billion, betting on a boom in online care and consultations spurred by the coronavirus crisis.

Virtual care company Teladoc to buy Livongo in $18.5 bln deal

Teladoc Health said on Wednesday it would buy Livongo Health Inc in a deal valued at $18.5 billion, in a bid to create a leader in virtual care.

BRIEF-Teladoc Issued $1 Bln Of 1.25% Convertible Senior Notes Due 2027

* TELADOC HEALTH INC - ON MAY 19 ISSUED $1 BILLION AGGREGATE PRINCIPAL AMOUNT OF 1.25% CONVERTIBLE SENIOR NOTES DUE 2027 Source text: (https://bit.ly/2zSdKZr) Further company coverage:

BRIEF-Teladoc Health Prices Upsized Offering Of $850 Million Of Convertible Senior Notes Due 2027

* TELADOC HEALTH PRICES UPSIZED OFFERING OF $850 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027

BRIEF-Teladoc Health Announces Proposed Offering Of $800 Million Of Convertible Senior Notes Due 2027

* TELADOC HEALTH ANNOUNCES PROPOSED OFFERING OF $800 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027 Source text for Eikon: Further company coverage:

BRIEF-Teladoc Health Reports First-Quarter 2020 Results

* Q1 REVENUE $180.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $178.2 MILLION

Teladoc Health sees revenue above estimates on spike in demand due to coronavirus

Teladoc Health Inc <TDOC.N> said on Tuesday it expected its first-quarter revenue above estimates, as the telemedicine provider experiences an unprecedented surge in demand for its services due to the new coronavirus outbreak.

BRIEF-Teladoc Health Sees Q1 2020 Revenue $180 Mln To $181 Mln

* AS A RESULT OF GLOBAL OUTBREAK OF COVID-19, TELADOC HEALTH HAS EXPERIENCED AN UNPRECEDENTED SURGE IN DEMAND FOR ITS SERVICES

Teladoc Health says daily patient visits rose 50% in past week

Teladoc Health Inc on Friday said it experienced a 50% spike in patient visit volume over the prior week, in what the telehealth company called an "unprecedented daily visit volume" in the United States, as the coronavirus spreads globally.

BRIEF-Teladoc Health Forecasts FY 2020 Revenue Between $695 Million And $710 Million

* TELADOC HEALTH REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS

BRIEF-Teladoc Issues $287.5 Mln Aggregate Principal Amount Of 1.375 Pct Convertible Senior Notes Due 2025

* TELADOC INC - ON MAY 8, 2018, CO ISSUED $287.5 MILLION AGGREGATE PRINCIPAL AMOUNT OF 1.375% CONVERTIBLE SENIOR NOTES DUE 2025 - SEC FILING

BRIEF-Teladoc Prices Upsized Offering Of $250 Mln Of Convertible Senior Notes Due 2025

* TELADOC PRICES UPSIZED OFFERING OF $250 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2025

BRIEF-Teladoc Announces Proposed Offering Of $225 Million Of Convertible Senior Notes Due 2025

* TELADOC ANNOUNCES PROPOSED OFFERING OF $225 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2025 Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up